Reporter brief
Exercise-based cardiac rehabilitation reduces myocardial infarction and hospitalisation in coronary heart disease.
What happened
Systematic review of 107 randomised trials (26,886 adults with coronary heart disease) comparing exercise-based cardiac rehabilitation versus no exercise control. At short-term follow-up (6-12 months), exercise reduced myocardial infarction (RR 0.72), all-cause hospitalisation (RR 0.65), and likely reduced all-cause mortality (RR 0.86). Health-related quality of life improved across multiple domains, and eight economic studies confirmed cost-effectiveness.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Meta analysis; Human.
Adults with coronary heart disease (CHD), mostly post-MI or post-revascularisation; mean age 47–81 years. 78% of trials included women, who represented 17% of total participants overall.
- Design
- Meta analysis
- Sample
- 26,886
- Journal
- The Cochrane Database of Systematic Reviews
- Published
- Sep 18, 2026
Effect size
Short-term follow-up (6–12 months): All-cause mortality RR 0.86 (95% CI 0.74–1.00, moderate-certainty); cardiovascular mortality RR 0.87 (95% CI 0.68–1.11, moderate-certainty); MI RR 0.72 (95% CI 0.54–0.95, high-certainty); CABG RR 1.00 (95% CI 0.78–1.28, high-certainty); PCI RR 0.86 (95% CI 0.65–1.13, moderate-certainty); all-cause hospitalisation RR 0.65 (95% CI 0.51–0.82, moderate-certainty); cardiovascular hospitalisation RR 0.80 (95% CI 0.35–1.82, low-certainty). Long-term follow-up (>12 months): exercise-based CR associated with reduced cardiovascular mortality and MI. HRQoL showed clinically meaningful increases across SF-36 subscales and EQ-5D scores up to 12 months. Eight economic evaluation studies showed exercise-based CR cost-effective.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Funding support from University of Glasgow, UK (for GD and RST) and Radboud University Medical Centre, NL (for FdV, DT and NS). Past NIHR Cochrane Infrastructure funding to Cochrane Heart. · Not reported.
Previous evidence
See the Exercise timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.